Ozempic’s Success Is Bad News for Rivals
October 23, 2023
7 min
Full
3,770 of 5,353
October 23, 2023
Ozempic’s Success Is Bad News for Rivals
0:00 / 7:10
Search the Record
Moment search isn’t open for this episode yet
When it opens, you’ll be able to type any phrase and jump straight to the second it was said.
Bloomberg Originals Episodes Around October 23, 2023
Episode 3,770 of 5,353 — walk the feed in the order it was published.
7:10This episodeOzempic’s Success Is Bad News for Rivals
Summary
<p>Bloomberg News Health Reporter Madison Muller discusses how the drug <a href="https://www.bloomberg.com/news/articles/2023-10-04/walmart-says-ozempic-weight-loss-drugs-causing-slight-pullback-by-shoppers">Ozempic</a> could <a href="https://www.bloomberg.com/news/newsletters/2023-10-18/ozempic-mounjaro-and-glp-1s-alternate-uses-and-drugmaker-implications">cut demand for big-money drugs</a> targeting a wide range of maladies, even Alzheimer’s. <br />Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.</p><p>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.</p>
Episode details and artwork are published by the show’s own feed. Sentinel plays short cited excerpts and links every episode back to its publisher.